Avigen, Inc. Announces First Quarter 2007 Earnings Conference Call
April 19 2007 - 9:00AM
PR Newswire (US)
Avigen to host conference call Tuesday, April 24, at 11:30 a.m. EDT
ALAMEDA, Calif., April 19 /PRNewswire-FirstCall/ -- Avigen, Inc.
(NASDAQ:AVGN), a biopharmaceutical company developing innovative
therapies for the treatment of neurological conditions, will hold
its quarterly conference call to discuss first quarter results on
Tuesday, April 24, 2007, at 11:30 a.m. EDT (8:30 a.m. PDT). Kenneth
Chahine, Chief Executive Officer, and Michael Coffee, Chief
Business Officer, can be heard by calling 800-706- 7745 (U.S.) or
617-614-3472 (non-U.S. locations) using passcode 12207133. This
call is being webcast by Thomson/CCBN and can be accessed at
Avigen's website at http://www.avigen.com/. The webcast is also
being distributed through the Thomson StreetEvents Network.
Individual investors can listen to the call at
http://www.earnings.com/, Thomson's individual investor portal,
powered by StreetEvents. Institutional investors can access the
call via Thomson StreetEvents (http://www.streetevents.com/), a
password-protected event management site. A rebroadcast of the call
will be available shortly after the conclusion of the session. The
replay may be accessed over the Internet at http://www.avigen.com/
or by calling 888-286-8010 (U.S.) or 617-801-6888 (non-U.S.
locations) using passcode 60387595. About Avigen Avigen, Inc. is a
biopharmaceutical company focused on unique small molecule
therapeutics and biologics to treat serious, chronic neurological
disorders, including neuropathic pain and neuromuscular spasm and
spasticity. For press releases and other corporate information,
visit our website at http://www.avigen.com/. DATASOURCE: Avigen,
Inc. CONTACT: Michael Coffee, Chief Business Officer of Avigen,
Inc., +1-510-748-7372 or Web site: http://www.avigen.com/
Copyright
Avigen (MM) (NASDAQ:AVGN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Avigen (MM) (NASDAQ:AVGN)
Historical Stock Chart
From Jul 2023 to Jul 2024